Navigation Links
CRH Medical Corporation announces substantial increase in patient visits
Date:2/5/2008

VANCOUVER, Feb. 5 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today for the year ended December 31, 2007, it had 13,461 patient visits at its Centers for Colorectal Health compared to 1,699 patient visits for the same period in 2006.

Commenting on this achievement, Edward Wright, CEO of CRH Medical Corporation stated, "In 2007, we demonstrated the strong demand for the CRH O'Regan hemorrhoid banding technology and treatment protocol. In 2008, we plan to open several additional Centers in new markets throughout the United States allowing CRH to further capitalize on this large and underserved market. According to the National Institutes of Health the prevalence rate of symptomatic hemorrhoids in the United States is approximately 4.4% of the population or 13.3 million people."

Centers open one year or longer continue to show strong growth, with patient visits increasing 485% for the three months ended December 31, 2007 compared to the same period in 2006.

Commenting on the CRH O'Regan Hemorrhoid Banding technology and treatment protocol, Dr. Iain Cleator, Chief Medical Director of CRH said, "The most important aspect of our technology and treatment protocol is that we are experiencing the same excellent results in each of our Centers. This means that our training methodology and treatment protocol is transferable and reproducible."

Dr. Carolyn Million, Medical Director of CRH's San Francisco Center, added, "As a Fellow of the American Society of Colon and Rectal Surgeons I have treated hemorrhoids for 15 years. In my opinion the CRH O'Regan banding technology and treatment protocol consistently provide a significantly higher level of patient satisfaction compared with other hemorrhoid treatments options."

About CRH Medical Corporation:

CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.

CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440, or ir@crhmedcorp.com; Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com, or the SEDAR website at http://www.sedar.com


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Phase II Medical Manufacturing Selects IQMS for ERP Solution
2. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
3. Presidents Proposed 2009 Medicare Budget Would Weaken Seniors Access to Durable Medical Equipment and Therapies Required in the Home
4. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
5. ATS Medical Expects Fourth Quarter Revenue to Increase by Approximately 32%
6. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
7. MCM Completes LAC+USC Replacement Medical Facility Project
8. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
9. Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation
10. Globus Medical Announces Record Revenue for 2007
11. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: